| 1 |
Chen S, Ji X, Zhao M, Jin J, Zhang H, Zhao L. Construction of chitooligosaccharide-based nanoparticles of pH/redox cascade responsive for co-loading cyclosporin A and AZD9291. Carbohydrate Polymers 2022;291:119619. [DOI: 10.1016/j.carbpol.2022.119619] [Reference Citation Analysis]
|
| 2 |
Ghosh S, Javia A, Shetty S, Bardoliwala D, Maiti K, Banerjee S, Khopade A, Misra A, Sawant K, Bhowmick S. Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches. J Control Release 2021;337:27-58. [PMID: 34273417 DOI: 10.1016/j.jconrel.2021.07.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Sawant SS, Patil SM, Shukla SK, Kulkarni NS, Gupta V, Kunda NK. Pulmonary delivery of osimertinib liposomes for non-small cell lung cancer treatment: formulation development and in vitro evaluation. Drug Deliv Transl Res 2021. [PMID: 34816394 DOI: 10.1007/s13346-021-01088-0] [Reference Citation Analysis]
|
| 4 |
Jing C, Li B, Tan H, Zhang C, Liang H, Na H, Chen S, Liu C, Zhao L. Alendronate-Decorated Nanoparticles as Bone-Targeted Alendronate Carriers for Potential Osteoporosis Treatment. ACS Appl Bio Mater 2021;4:4907-16. [PMID: 35007039 DOI: 10.1021/acsabm.1c00199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 5 |
Liu Y, Xu L, Zhang Q, Kang Y, Liu L, Liu Z, Wang Y, Jiang X, Shan Y, Luo R, Cui X, Yang Y, Yang X, Liu X, Li Z. Localized Myocardial Anti-Inflammatory Effects of Temperature-Sensitive Budesonide Nanoparticles during Radiofrequency Catheter Ablation. Research 2022;2022:1-11. [DOI: 10.34133/2022/9816234] [Reference Citation Analysis]
|
| 6 |
Liu P, Li H, Li R, Geng Y, Gong J, Xu H, Xu Z, Shi J. Nanoencapsulation of chitooligosaccharides enhances its oral bioavailability and anti-liver fibrotic effects. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.111471] [Reference Citation Analysis]
|
| 7 |
Gilani SJ, Bin-jumah MN, Imam SS, Zafar A, Yasir M, Alshehri S, Ghuneim MM. Formulation of Osimertinib Nano Lipid Carriers: Optimization, Characterization and Cytotoxicity Assessment. J Clust Sci. [DOI: 10.1007/s10876-022-02282-x] [Reference Citation Analysis]
|
